Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
PIAS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
GORASP2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CXorf38 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FUT6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC101929373 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
AP3S1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZNF184 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TET3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TAF13 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PRPF40A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RMI1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
UG0898H09 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
MDM1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FBXO21 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ECHDC1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LYSMD2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TAF4B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CEP57 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DNAJC10 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on